ArticleEClinicalMedicine2026

Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial.

M Parellada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.